SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-051037
Filing Date
2017-08-10
Accepted
2017-08-10 16:01:38
Documents
59
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-13337_110q.htm 10-Q 937319
2 EX-10.1 a17-13337_1ex10d1.htm EX-10.1 84283
3 EX-31.1 a17-13337_1ex31d1.htm EX-31.1 12747
4 EX-31.2 a17-13337_1ex31d2.htm EX-31.2 12752
5 EX-32.1 a17-13337_1ex32d1.htm EX-32.1 7328
12 GRAPHIC g133371kgi001.jpg GRAPHIC 4768
  Complete submission text file 0001104659-17-051037.txt   4071726

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT catb-20170630.xml EX-101.INS 746040
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT catb-20170630.xsd EX-101.SCH 33687
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT catb-20170630_cal.xml EX-101.CAL 39633
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT catb-20170630_lab.xml EX-101.LAB 340037
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT catb-20170630_pre.xml EX-101.PRE 244377
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT catb-20170630_def.xml EX-101.DEF 125184
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 171021433
SIC: 2834 Pharmaceutical Preparations